AorTech looks to biomaterials future with Elast-Eon deal
This article was originally published in Clinica
Executive Summary
Scottish medical technology company AorTech International has taken a significant step towards its re-emergence as a biomaterials company with the signing this month of a global licensing deal for Elast-Eon.